The three Fes inhibitors as well as tandutinib each induced significant apoptosis under these conditions in all three Flt3-ITD+ AML cell lines but not in THP-1 cells, consistent with the observation that Fes is constitutively active in Flt3-ITD+ AML cells [14] (Fig 3). This evidence concerns the gene FES and acute myeloid leukemia.